SCHEMBL6152240

SCHEMBL6152240

C=CCO/N=C(/C)COc1c(S(=O)(=O)CC)ccc(C(=O)C2C(=O)CCCC2=O)c1Cl

nearest known ligand 0.41

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6152251 1.00 ALDH1A1 (0.36) ALDH1A1
SCHEMBL6151867 0.84 ALDH1A1 (0.41) ALDH1A1
SCHEMBL6425424 0.84 ALDH1A1 (0.41) ALDH1A1
SCHEMBL6426491 0.83 ALDH1A1 (0.34) ALDH1A1
SCHEMBL6151821 0.83 ALDH1A1 (0.34) ALDH1A1
SCHEMBL6152976 0.83 ALDH1A1 (0.35) ALDH1A1
SCHEMBL6428039 0.83 ALDH1A1 (0.42) ALDH1A1
SCHEMBL6428042 0.83 ALDH1A1 (0.42) ALDH1A1
SCHEMBL8848046 0.80 ALDH1A1 (0.44) ALDH1A1
SCHEMBL3255597 0.78 NPC1 (0.35) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6930208-B2 3-Keto- or 3- oxime-ether-substituted benzoylcyclohexanediones BAYER CROPSCIENCE GMBH (DE) 2005-08-16 US disclosed
EP-1497251-A1 3-KETO OR 3-OXIMOETHER SUBSTITUTED BENZOYLCYCLOHEXANEDIONES Bayer CropScience GmbH (DE) 2005-01-19 EP disclosed
US-20040204320-A1 3-Keto- or 3- oxime-ether-substituted benzoylcyclohexanediones BAYER CROPSCIENCE GMBH (DE) 2004-10-14 US disclosed
WO-2003084912-A1 3-KETO OR 3-OXIMOETHER SUBSTITUTED BENZOYLCYCLOHEXANEDIONES BAYER CROPSCIENCE GMBH (DE) 2003-10-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040204320-A1 3-Keto- or 3- oxime-ether-substituted benzoylcyclohexanediones CBR3, CBR1, CYP2E1 ALDH1A1 397/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.